...PIK3CA/AKT1 mutation status. These findings raise interesting questions about the role of PIK3CA/AKT pathway in breast c...
...PIK3CA gene mutations by direct sequencing. EGFR overexpression and loss of PTEN expression characterized the majority o...
...PIK3CA mutations).,Two US nationwide prospective cohort studies.,Patients with rectal and colon cancer (N=918).,The nega...
...PIK3CA, FGFR1). Other regions contain putative oncogenes that may be targeted in the future.,Using single nucleotide pol...
...PIK3CA, encoding the catalytic subunit p110α of PI3K. The resulting activation of AKT (phosphoSer473) also p...
...PIK3CA and PTEN, and PTEN promoter hypermethylation.,We found 46% ER/PR-positive tumours, overexpression of EGFR (15%), ...
...PIK3CA mutation had stable disease (SD) for 4 months. Two other patients without apparent PI3K pathway aberrations achie...
...PIK3CA mutations. When compared to stage-matched controls, patients with early-stage ovarian CCCs may have a better prog...
...PIK3CA); and v-raf murine sarcoma viral oncogene homolog B1 (BRAF) mutations, and immunohistochemistry was performed to ...
...PIK3CA mutations significantly correlated with DLC1 hypermethylation. Thus, aberrant DLC1 methylation and PIK3CA mutatio...
联系地址
山东省济南市章丘区文博路2号
齐鲁师范学院 genelibs生信实验室
山东省济南市高新区舜华路750号
大学科技园北区F座4单元2楼
电话： 0531-88819269
版权所有 © 2025.Genelibs 济南弘晖生物技术有限公司 鲁ICP备20007159号-2
